Tag: analytics

Biostatistics for RWE: Best Practices for High-Validity Real-World Evidence Biostatistics for RWE: Best Practices for High-Validity Real-World Evidence As clinical trial researchers and professionals in clinical operations, regulatory affairs, and medical affairs, understanding the nuances of biostatistics in the context of Real-World Evidence (RWE) is paramount. This guide provides a step-by-step breakdown of best practices…

Read More “Biostatistics for RWE: Best Practices for High-Validity Real-World Evidence” »

How to Design Biostatistics for RWE for FDA, EMA and HTA Acceptance How to Design Biostatistics for RWE for FDA, EMA and HTA Acceptance In an era where the landscape of clinical research is shifting towards real-world evidence (RWE), designing biostatistical methodologies to support RWE studies has emerged as a pivotal component for regulatory acceptance…

Read More “How to Design Biostatistics for RWE for FDA, EMA and HTA Acceptance” »

Biostatistics for RWE in Practice: Step-by-Step Guide for Real-World Researchers Biostatistics for RWE in Practice: Step-by-Step Guide for Real-World Researchers As the field of clinical research evolves, the integration of biostatistics in real-world evidence (RWE) studies has become increasingly critical. Biostatistics plays a foundational role in ensuring data reliability, robustness, and regulatory compliance. This comprehensive…

Read More “Biostatistics for RWE in Practice: Step-by-Step Guide for Real-World Researchers” »

Common Biases in Biostatistics for RWE—and How to Correct Them In the field of clinical research, particularly when dealing with Real-World Evidence (RWE), understanding biases in biostatistics is crucial for accurate interpretation of data. RWE derived from observational studies often encounters several biases that can significantly influence study findings. This comprehensive guide aims to equip…

Read More “Common Biases in Biostatistics for RWE—and How to Correct Them” »

Aligning Biostatistics for RWE With Regulatory and HTA Expectations Aligning Biostatistics for RWE With Regulatory and HTA Expectations Real-world evidence (RWE) has emerged as a critical component in the clinical research landscape, particularly for regulatory submissions and health technology assessments (HTAs). This comprehensive guide provides clinical operations, regulatory affairs, and medical affairs professionals with a…

Read More “Aligning Biostatistics for RWE With Regulatory and HTA Expectations” »